These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37924341)

  • 1. STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.
    Xu D; Lu X; Yang F; Jiang Z; Yang S; Bi L; Liu J; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):641-655. PubMed ID: 37924341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis.
    Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L
    Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer.
    Li C; Saladin RJ; Cai W; Chen W
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2758-2760. PubMed ID: 38771515
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel
    Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
    Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury.
    Xu D; Yang F; Chen J; Zhu T; Wang F; Xiao Y; Liang Z; Bi L; Huang G; Jiang Z; Shan H; Li D
    Acta Pharm Sin B; 2023 May; 13(5):2124-2137. PubMed ID: 37250155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of
    Liu H; Sun Y; Li J; Chen Y; Liu J; Fang J; Yang H; Feng L; Peng S; Zhuang R; Guo Z; Zhang X
    Mol Pharm; 2023 Jul; 20(7):3529-3538. PubMed ID: 37243620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
    Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.
    Shi J; Liu C; Luo S; Cao T; Lin B; Zhou M; Zhang X; Wang S; Zheng T; Li X
    Cell Immunol; 2021 Aug; 366():104384. PubMed ID: 34182334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
    Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X
    Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation and pilot clinical study of [
    Ma X; Zhou X; Hu B; Li X; Yao M; Li L; Qin X; Li D; Yao Y; Hou X; Liu S; Chen Y; Wang Z; Zhou W; Li N; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3838-3850. PubMed ID: 37555904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Chen M; Chen Z; Castillo JB; Cui L; Zhou K; Shen B; Xie J; Chin FT; Rao J
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3386-3399. PubMed ID: 33712870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [
    Rapic S; Vangestel C; Elvas F; Verhaeghe J; den Wyngaert TV; Wyffels L; Pauwels P; Staelens S; Stroobants S
    Mol Imaging Biol; 2017 Aug; 19(4):560-569. PubMed ID: 28050749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [
    Liang K; Abt ER; Le TM; Cho A; Dann AM; Cui J; Li L; Rashid K; Creech AL; Wei L; Ghukasyan R; Rosser EW; Wu N; Carlucci G; Czernin J; Donahue TR; Radu CG
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.